University of Auckland
Auckland 91346
2 studies enrolling now · 14 studies all time
What they study most
Becker Muscular Dystrophy, Breast Cancer, Colon Cancer, Colorectal Cancer, Colorectal Carcinoma, DM1, Focal Epilepsy, Focal Onset Seizures, Heart Failure, Liver Metastases, Macular Degeneration, Major Depressive Disorder
Studies at this site
- Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) — Recruiting now
- An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
- Defining Endpoints in Becker Muscular Dystrophy — Running, not enrolling
- A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
- A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD) — Completed
- A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease — Completed
- Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed
- Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation — APPROVED_FOR_MARKETING
- An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients — Completed
- HF Assessment With BNP in the Home: Part II — Stopped early
- Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) — Completed
- A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration — Completed
- FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer — Completed
- International Study to Predict Optimised Treatment - in Depression — Status unconfirmed